Imaging3?, Inc. (OTCBB: IMGG), developer of a breakthrough medical

imaging device that produces 3D medical diagnostic images of virtually

any part of the human body in real-time, announced that at 2:00pm PDT

(5:00pm EDT), Monday, May 21st, 2012, the company's CEO, Mr. Dean

Janes, will be hosting a conference call. To join the conference call,

please call 1-888-205-6786 and enter passcode 161478 followed by the

pound sign (#). You will be connected to the conference call in a

listen only mode, and then lines will be opened for questions

following the presentation.

The purpose of the call is to update Shareholders and other interested

parties of the current developments with the company.

A limited number of lines will be available for this conference call.

The lines will open up 5 minutes prior to the start of the call.

A recording of the conference call will be made available on the

company's website as soon as it is available. Imaging3 will notify

shareholders and others who subscribe to the company newsletter.

Anyone who would like to be added to this list is encouraged to

sign-up for the e-mail based newsletter on the company's website using

the following link --

About Imaging3Imaging3, Inc., founded in 1993, is a leading provider

of advanced technology medical imaging devices. The Company has

developed a breakthrough medical imaging device that produces 3D

medical diagnostic images of virtually any part of the human body in

real-time. Because these 3D images are instantly constructed in

real-time, they can be used for any current or new medical procedures

in which multiple frames of reference are required to perform medical

procedures on or in the human body. Visit the company's website at for more information

Safe Harbor Statement Matters discussed in this press release contain

forward-looking statements within the meaning of the Private

Securities Litigation Reform Act of 1995. When used in this press

release, the words "anticipate," "believe," "estimate," "may,"

"intend," "expect" and similar expressions identify such

forward-looking statements. Actual results, performance or

achievements could differ materially from those contemplated,

expressed or implied by the forward-looking statements contained

herein. These forward-looking statements are based largely on the

expectations of the Company and are subject to a number of risks and

uncertainties. These include, but are not limited to, risks and

uncertainties associated with: the impact of economic, competitive and

other factors affecting the Company and its operations, markets,

product, and distributor performance, technological obsolescence,

competition from other medical instrument(s) and imaging companies,

lack of capital, unexpected costs, failure or delay of FDA approval,

absence of revenue, the impact on the national and local economies

resulting from an economic recession or terrorist actions, and U.S.

actions subsequently; unavailability of financing for the Company or

its customers, product malfunction and potential product liability

claims, and other factors detailed in reports filed by the Company.